Vietnam's surgical devices market is on a strong growth trajectory, reflecting the country's continued investment in healthcare infrastructure and increasing demand for advanced surgical care.

Industry forecasts estimate the market will grow from US$194.4 million in 2024 to approximately US$321.4 million by 2030, representing a robust growth rate of 8.7%.

The market is being driven by several key trends, including:

• Expansion of both public and private hospital infrastructure.
• Rising surgical volumes associated with an ageing population and increasing prevalence of chronic diseases.
• Growing adoption of minimally invasive surgical (MIS) procedures.
• Continued government investment in healthcare modernisation and medical technology.
• Increasing demand for high-quality imported surgical equipment and instruments.

Among the fastest-growing product categories are minimally invasive surgical instruments, electrosurgical devices, endoscopic and laparoscopic equipment, surgical staplers, orthopaedic instruments, and cardiovascular surgical devices.

Hospitals remain the primary purchasers of surgical devices across Vietnam, while ambulatory surgery centres are expected to experience the strongest growth as more procedures transition to outpatient settings.

Leading global manufacturers—including Medtronic, Johnson & Johnson MedTech, Stryker, B. Braun, Olympus, Karl Storz, Smith+Nephew, and Zimmer Biomet—continue to strengthen their presence in the Vietnamese market, supporting the country's evolving surgical capabilities with innovative technologies and advanced clinical solutions.

As Vietnam continues to modernise its healthcare system, the surgical devices sector presents significant opportunities for manufacturers, distributors, and healthcare providers. With sustained investment, increasing procedural volumes, and a growing focus on minimally invasive surgery, the market is expected to remain one of Southeast Asia's most attractive destinations for medical device growth through the end of the decade.